this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

AZM

5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE

AZM is found in 29 entries

AZM as free ligands, exist in 29 entries. Example includes: 4K0S 2UY4 4G0C

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE
IdentifiersN-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide
FormulaC4 H6 N4 O3 S2
Molecular Weight222.25 g/mol
TypeNON-POLYMER
Isomeric SMILESCC(=O)Nc1nnc(s1)S(N)(=O)=O
InChIInChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)
InChIKeyBZKPWHYZMXOIDC-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count19
Chiral Atom Count0
Chiral Atomsn/a
Bond Count19
Aromatic Bond Count5
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00819 Different stereochemistry
NameAcetazolamide
Groups
  • approved
  • vet_approved
DescriptionOne of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Synonyms
  • 2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide
  • 5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide
  • 5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide
  • Acetazolamid
  • Acetazolamida
SaltsAcetazolamide Sodium
Brand Names
  • Acetazolam
  • Acetazolamide
  • Acetazolamide for Injection, USP
  • Diamox IV 500mg
  • Diamox Pws 500mg/vial
Affected OrganismHumans and other mammals
IndicationFor adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
PharmacologyAcetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion, in the treatment of certain convulsive disorders and in the promotion of diuresis in instances of abnormal fluid retention. Acetazolamide is not a mercurial diuretic. Rather, it is a nonbacteriostatic sulfonamide possessing a chemical structure and pharmacological activity distinctly different from the bacteriostatic sulfonamides.
Mechanism of actionThe anticonvulsant activity of Acetazolamide may depend on a direct inhibition of carbonic anhydrase in the CNS, which decreases carbon dioxide tension in the pulmonary alveoli, thus increasing arterial oxygen tension. The diuretic effect depends on the inhibition of carbonic anhydrase, causing a reduction in the availability of hydrogen ions for active transport in the renal tubule lumen. This leads to alkaline urine and an increase in the excretion of bicarbonate, sodium, potassium, and water.
Route of administration
  • Intravenous
  • Oral
Categories
  • Anticonvulsants
  • Antiglaucoma Preparations and Miotics
  • Azoles
  • Carbonic Anhydrase Inhibitors
  • Cardiovascular Agents
ATC-CodeS01EC01
AHFS-Code52:10.00
CAS number59-66-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682